Jean‐Paul Cano
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 9
-
- Cancer therapeutics and mechanisms 6
- Co-authors
- Roger Rahmani (10 shared papers)Jacques Barbet (8 shared papers)Claude Aubert (5 shared papers)Gérard Fabre (5 shared papers)Philippe Coassolo (4 shared papers)Marie Martin (3 shared papers)Laurence Vian (4 shared papers)Roger Favre (3 shared papers)
- Journals
- Biochemical Pharmacology (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2 papers)International Journal of Cancer (2 papers)Clinica Chimica Acta (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Jean‐Paul Cano
42 papers receiving 883 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 170
- Oncology 324
- Toxicology 26
- Analytical Chemistry 77
- Pediatrics, Perinatology and Child Health 100
Countries citing papers authored by Jean‐Paul Cano
This map shows the geographic impact of Jean‐Paul Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Paul Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Paul Cano more than expected).
Fields of papers citing papers by Jean‐Paul Cano
This network shows the impact of papers produced by Jean‐Paul Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Paul Cano. The network helps show where Jean‐Paul Cano may publish in the future.
Co-authors
The 25 scholars most cited alongside Jean‐Paul Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 88 | |
| 2 | 1982 | 87 | |
| 3 | 1989 | 58 | |
| 4 | Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine). | 1987 | 52 |
| 5 | 1986 | 51 | |
| 6 | In vitro formation of polyglutamyl derivatives of methotrexate and 7-hydroxymethotrexate in human lymphoblastic leukemia cells. | 1983 | 46 |
| 7 | Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine). | 1984 | 44 |
| 8 | 1999 | 42 | |
| 9 | 2000 | 41 | |
| 10 | 1990 | 35 | |
| 11 | 1991 | 30 | |
| 12 | Kinetics and metabolism of a new fluoropyrimidine, 5'-deoxy-5-fluorouridine, in humans. | 1983 | 26 |
| 13 | 1987 | 19 | |
| 14 | 1984 | 19 | |
| 15 | 1984 | 19 | |
| 16 | 1983 | 19 | |
| 17 | 1986 | 18 | |
| 18 | 1991 | 17 | |
| 19 | 1985 | 17 | |
| 20 | 1985 | 16 |
About Jean‐Paul Cano
Jean‐Paul Cano is a scholar working on Oncology, Molecular Biology, Pharmacology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health, having authored 42 papers that have together received 937 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Pharmacogenetics and Drug Metabolism (6 papers), Cancer therapeutics and mechanisms (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Neuroscience and Neuropharmacology Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Analytical Methods in Pharmaceuticals (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Pharmacology (170 citations), Oncology (324 citations), Toxicology (26 citations), Analytical Chemistry (77 citations) and Pediatrics, Perinatology and Child Health (100 citations). Jean‐Paul Cano has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Roger Rahmani, Jacques Barbet, Claude Aubert, Gérard Fabre, Philippe Coassolo, Marie Martin, Laurence Vian, Roger Favre, B Hœrni and Athanassios Iliadis. Their work appears in journals such as Biochemical Pharmacology, Cancer Chemotherapy and Pharmacology, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, International Journal of Cancer and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.